A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
Public ClinicalTrials.gov record NCT04308681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants With Pulmonary Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.
Study identification
- NCT ID
- NCT04308681
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 403 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2020
- Primary completion
- Aug 3, 2022
- Completion
- Sep 21, 2023
- Last update posted
- Feb 2, 2026
2020 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0032 | Birmingham | Alabama | 35294 | — |
| Local Institution | Phoenix | Arizona | 85006 | — |
| Local Institution - 0028 | Los Angeles | California | 90024 | — |
| Local Institution - 0043 | Stanford | California | 94305-528 | — |
| University of Colorado Anschutz Medical Campus-Department of Medicine | Aurora | Colorado | 80045 | — |
| Local Institution - 0006 | Denver | Colorado | 80206 | — |
| Local Institution - 0171 | New Haven | Connecticut | 06520 | — |
| Local Institution - 0035 | Gainesville | Florida | 32610 | — |
| Local Institution - 0166 | Orlando | Florida | 32803 | — |
| Local Institution - 0078 | Atlanta | Georgia | 30309 | — |
| Local Institution - 0031 | Kansas City | Kansas | 66160 | — |
| Local Institution - 0154 | Baltimore | Maryland | 21224 | — |
| Local Institution - 0003 | Boston | Massachusetts | 02135 | — |
| Local Institution - 0030 | Chesterfield | Missouri | 63017 | — |
| Local Institution - 0036 | St Louis | Missouri | 63110 | — |
| Local Institution - 0029 | Cincinnati | Ohio | 45267 | — |
| Local Institution - 0164 | Columbus | Ohio | 43221 | — |
| Local Institution | Hershey | Pennsylvania | 17033 | — |
| Local Institution | Nashville | Tennessee | 37232 | — |
| Local Institution - 0096 | Charlottesville | Virginia | 22908 | — |
| Local Institution | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04308681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04308681 live on ClinicalTrials.gov.